Page last updated: 2024-11-02

benoxinate and Apraxias

benoxinate has been researched along with Apraxias in 1 studies

benoxinate: RN given refers to parent cpd; structure
oxybuprocaine : A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester "caine") used especially in ophthalmology and otolaryngology.

Apraxias: A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor (see APRAXIA, IDEOMOTOR) and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. (From Adams et al., Principles of Neurology, 6th ed, pp56-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kohsaka, M1
Oeda, T1
Umemura, A1
Tomita, S1
Park, K1
Yamamoto, K1
Sugiyama, H1
Sawada, H1

Other Studies

1 other study available for benoxinate and Apraxias

ArticleYear
Oxybuprocaine for apraxia of lid opening in Parkinson's disease: A placebo-controlled pilot trial.
    Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:3

    Topics: Anesthetics, Local; Apraxias; Eyelids; Female; Humans; Male; Parkinson Disease; Pilot Projects; Proc

2018